The report is the latest indictment of America’s broken healthcare system.
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
Optum RX, CVS Caremark and Express Scripts are marking up drugs that treat cancer and multiple sclerosis by more than ...
An Alabama lawmaker believes prescription care management should be a legislative priority during the upcoming session.
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...
The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...
The Big 3 companies acting as intermediaries between drugmakers and insurance providers made billions by needlessly jacking ...
WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...